Article

(2021) Genomic Instability in Cancer: Molecular Mechanisms and Therapeutic Potentials. Current Pharmaceutical Design. pp. 3161-3169. ISSN 1381-6128

(2021) MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer. Journal of oncology. p. 3408937. ISSN 1687-8450 (Print) 1687-8450 (Linking)

(2021) The Role of Non-coding Genome in Cancer-associated Fibroblasts; State-of-the-Art and Perspectives in Cancer Targeted Therapy. Current Drug Targets. pp. 1524-1535. ISSN 1389-4501

(2021) The Role of Non-coding Genome in Cancer-associated Fibroblasts; Stateof- the-Art and Perspectives in Cancer Targeted Therapy. Current Drug Targets. pp. 1524-1535. ISSN 1873-5592 (Electronic) 1389-4501 (Linking)

(2021) The role of non-coding genome in the behavior of infiltrated myeloid-derived suppressor cells in tumor microenvironment; a perspective and state-of-the-art in cancer targeted therapy. Progress in Biophysics & Molecular Biology. pp. 17-26. ISSN 0079-6107

(2020) Common therapeutic advances for Duchenne muscular dystrophy (DMD). International Journal of Neuroscience. p. 20. ISSN 0020-7454

(2020) MicroRNA and Exosome in Retinal-related diseases: Their roles in the pathogenesis and diagnosis. Combinatorial chemistry & high throughput screening. ISSN 1875-5402 (Electronic) 1386-2073 (Linking)